2016 American Transplant Congress Archives - Page 4 of 180

Vaccination Compliance in Listed Kidney Transplant Candidates: A Retrospective Chart Review.

I. Tawhari,¹ C. Staffeld-Coit,² J. Garcia-Diaz.¹
Vaccination of the Pediatric Patient After Transplantation – Attitudes and Knowledge of the General Pediatrician.

B. Gonzalez,¹ S. Worley,² A. Tang,² C. Saracusa,¹ J. Goldfarb.¹
Vaccination Status and Titers Before and After Pediatric Renal Transplantation: An Analysis of the CERTAIN Registry.

B. Höcker,¹ M. Aguilar,¹ P. Schnitzler,² L. Pape,² L. Dello Strologo,² N. Webb,² M. Bald,² G. Genc,² H. Billing,² J. König,² A. Büscher,² F. Thiel,² S. Marks,² M. Pohl,² M. Wigger,² R. Topaloglu,² A. Fichtner,¹ S. Rieger,¹ K. Krupka,¹ B. Tönshoff.¹
Validation of a Simplified Cost-Effective Clinical Risk Stratification That Predicts Myocardial Ischemic Events in Kidney Transplant Candidates.

T. Jiamjariyapon,^1,2 N. Townamchai,^2,3 N. Garg,² M. Pavlakis,² A. Chandraker.²
Validation of SUITO Index and C-Peptide/Glucose Creatinine Ratio as Convenient Tools for the Evaluation of the Short and Long-Term Islet Allograft Function.

J. Gołębiewska,¹ J. Solomina,² S. Matosz,² C. Thomas,³ L. Schenck,² K. Golab,² W. Chon,³ S. Ramachandran,² M. Tibudan,² A. Dębska-ŚLizień,¹ B. Rutkowski,¹ P. Witkowski.²
Validation of the Kidney Donor Risk Index (KDRI) in the Australian and New Zealand Kidney Transplant Population.

P. Clayton,^1,2,3 S. White,^1,4 S. McDonald,^1,2,3 S. Chadban.^1,4,5
Validation of the Newly Developed North America Islet Donor Scoring System in the Medium Volume Islet Transplant Center.

J. Solomina,¹ S. Matosz,¹ M. Sledzinski,² J. Golebiewska,³ O. Savaril,¹ L.-J. Wang,⁴ T. Kin,⁵ K. Golab,¹ S. Ramachandran,¹ M. Tibudan,¹ L. Schenck,¹ W. Chon,⁶ C. Thomas,⁶ P. Witkowski.¹
Variation in Co-Medication Use According to Kidney Transplant Immunosuppressive Regimen: Application of Integrated Registry and Pharmacy Claims Data.

K. Lentine,¹ A. Naik,² M. Schnitzler,¹ D. Axelrod,³ J. Chen,¹ D. Brennan,⁴ D. Segev,⁵ B. Kasiske,⁶ H. Randall,¹ V. Dharnidharka.⁴
Vascular Composite Allotransplantation Collaborative Initiative Biobank: Bringing the Power Back to Research.

J. Cheeseman, M.-B. Joshi, F. Leopardi, R. Osborne, D. Conlon, L. Stempora, M. Song, L. Cendales.
Vascular Endothelial Cell Activation by Mitochondria Links Innate and Adaptive Immune Responses to Allograft Injury.

F. Feng, H. Xu, L. Lin, A. Kirk, T. Brennan.
Vascularized Composite Allograft Tolerance with Transient High-Dose Tacrolimus Across a Full MHC Mismatch in a Large Animal Model.

H. Wang, E. Swanson, H.-T. Cheng, J. Walch, J. Alonso-Esclante, K. Kolegraff, J. Lopez, G. Furtmuller, B. Oh, A. Quan, J. Budihardjo, S. AlFadil, S. Mulla, P. Akre, J. Sacks, S. Bonawitz, G. Raimondi, J. Shores, D. Cooney, W. Lee, G. Brandacher.
VDJ Immune Repertoire Sequencing Predicts Patients at Risk of Alloimmune Injury.

M. Sirota,¹ T. Sigdel,¹ S. Boyd,² A. Fire,² M. Sarwal.¹
Viral Gastroenteritis in Adult and Pediatric Solid Organ Transplant (SOT) Patients.

C. Hernández Garcia,¹ B. Lee,¹ X. Pang,² H. Yuan Zhou,¹ J. Preikisatis.¹
Virological Profile of Deceased Organ Donors in the UK.

M. Lawrance,¹ K. Davison,¹ I. Ushiro-Lumb,² S. Lattimore (deceased),¹ S. Brailsford.^1,2
Virological Response at 4 Weeks With a Sofosbuvir-Based Antiviral Regimen in Liver Transplant Recipients with Recurrent Hepatitis C.

T. Pastrana-Camacho,¹ M. Bradley,¹ H. Winters,¹ S. Black,² K. Porter,³ K. Mumtaz.⁴
Virtual Crossmatch in Simultaneous Pancreas-Kidney Transplant.

E. Bevilaqua Rangel,¹ A. Miziara Gonzalez,¹ C. Santiago Melaragno,¹ J. de Sa,¹ M. Moura Linhares,¹ A. Salzedas-Neto,¹ R. de Marco,² M. de Lima,² J. Medina-Pestana.¹
Virtual Crossmatching Under the New KAS: Safely Bypassing a Physical Crossmatch When Allocating Kidneys to Highly Sensitized Candidates.

R. Bray,¹ R. Parsons,² N. Turgeon,² H. Gebel.¹
Visceral Adiposity Is Associated with Increased Recurrence of Hepatocellular Carcinoma Following Liver Transplantation.

A. Mathur, L. Boyangzi, M. Prince, J. Guarrera, B. Samstein, A. Griesemer, K. Halazun, T. Kato, J. Emond.
VO_2peak Outperforms Troponin T for Risk Prediction of Cardiovascular Disease and All-Cause Mortality in Patients with End Stage Renal Disease Being Evaluated for Kidney Transplant.

H. Chakkera,¹ C. Lee,² J. Dickinson,^1,2 B. Kaplan,^1,2 I. Qaqish,¹ S. Behmen,¹ R. Heilman,¹ H. Khamash,¹ J. Huskey,¹ S. Nair,¹ R. Scott,¹ D. Steidley,¹ M. Temkit,¹ S. Angadi.^1,2